Risultati della ricerca - Signe Borgquist

Understanding the role of obesity in endocrine therapy for postmenopausal breast cancer: significance of the BIG 1–98 and ATAC trial data di Sixten Harborg, Signe Borgquist

Testo

Exploring the Impact of Initiating Endocrine Therapy on Metabolic Health in Early Breast Cancer: Protocol for the Prospective Follow-Up EMETA-Study di Lærke Nissen, Jonas Busk Holm, Signe Borgquist

Testo

Long-term cancer risk in heterozygous familial hypercholesterolemia relatives: a 25-year cohort study di Kasper Aalbæk Kjærgaard, Sixten Harborg, Henrik Kjærulf Jensen, Signe Borgquist

Testo

High CYP27A1 expression is a biomarker of favorable prognosis in premenopausal patients with estrogen receptor positive primary breast cancer di Maria Inasu, Pär-Ola Bendahl, Mårten Fernö, Per Malmström, Signe Borgquist, Siker Kimbung

Testo

Up-regulation of intra-tumour LDLR gene expression is associated with statin treatment and better prostate cancer prognosis di Kia Eistrup Fonfara, Jacob Fredsøe, Benedicte Ulhøi, Signe Borgquist, Michael Borre, Karina Dalsgaard Sørensen

Testo

Feasibility of an exercise program in endocrine-treated metastatic breast cancer patients with overweight: protocol for the FEMA study di May Wissing, Pernille Skovlund, Susanne Drysdale, Ali Amidi, Robert Zachariae, Tinne Laurberg, Signe Borgquist

Testo

Overweight and prognosis in triple-negative breast cancer patients: a systematic review and meta-analysis di Sixten Harborg, Robert Zachariae, Julia Olsen, Maja Johannsen, Deirdre Cronin-Fenton, Henrik Bøggild, Signe Borgquist

Testo

WHO-recommended levels of physical activity in relation to mammographic breast density, mammographic tumor appearance, and mode of detection of breast cancer di Öykü Boraka, Hanna Sartor, Li Sturesdotter, Per Hall, Signe Borgquist, Sophia Zackrisson, Ann H. Rosendahl

Testo

Obesity and breast cancer prognosis: pre-diagnostic anthropometric measures in relation to patient, tumor, and treatment characteristics di Sixten Harborg, Maria Feldt, Deirdre Cronin-Fenton, Marie Klintman, Susanne O. Dalton, Ann H. Rosendahl, Signe Borgquist

Testo

HbA1c levels and breast cancer prognosis in women without diabetes di Jonas Busk Holm, Jens Meldgaard Bruun, Peer Christiansen, Reimar Wernich Thomsen, Jan Frystyk, Deirdre Cronin-Fenton, Signe Borgquist

Testo

HbA1c screening in patients with early breast cancer receiving endocrine therapy di Lærke Nissen, Stine Blaabjerg Skovbjerg, Jonas Busk Holm, Morten Haaning Charles, Ole Lindgård Dollerup, Tinne Laurberg, Signe Borgquist

Testo

Low-Grade Inflammation, Oxidative Stress and Risk of Invasive Post-Menopausal Breast Cancer - A Nested Case-Control Study from the Malmö Diet and Cancer Cohort. di Joana A Dias, Gunilla N Fredrikson, Ulrika Ericson, Bo Gullberg, Bo Hedblad, Gunnar Engström, Signe Borgquist, Jan Nilsson, Elisabet Wirfält

Testo

Changes in experienced quality of oncological cancer care during the COVID-19 pandemic based on patient reported outcomes – a cross-sectional study di Ninna Aggerholm-Pedersen, Lise Bech Jellesmark Thorsen, Nina Møller Tauber, Josefine Tingdal Danielsen, Katrine Løppenthin, Signe Borgquist, Christoffer Johansen, Robert Zacharie

Testo

The association between body mass index and neoadjuvant chemotherapy response in patients with breast cancer di Jonas Busk Holm, Stine Blaabjerg Skovbjerg, Hanne Melgaard Nielsen, Peer Christiansen, Jens Meldgaard Bruun, Jan Alsner, Deirdre Cronin-Fenton, Signe Borgquist

Testo

Road traffic noise and breast cancer: DNA methylation in four core circadian genes di Jesse D. Thacher, Anastasiia Snigireva, Ulrike Maria Dauter, Mathilde N. Delaval, Anna Oudin, Kristoffer Mattisson, Mette Sørensen, Signe Borgquist, Maria Albin, Karin Broberg

Testo

Increased lesion detectability in patients with locally advanced breast cancer—A pilot study using dynamic whole-body [18F]FDG PET/CT di Mette Abildgaard Pedersen, André H. Dias, Karin Hjorthaug, Lars C. Gormsen, Joan Fledelius, Anna Lyhne Johnsson, Signe Borgquist, Trine Tramm, Ole Lajord Munk, Mikkel Holm Vendelbo

Testo

Low-dose tamoxifen treatment reduces collagen organisation indicative of tissue stiffness in the normal breast: results from the KARISMA randomised controlled trial di Sara Göransson, Pablo Hernández-Varas, Mattias Hammarström, Roxanna Hellgren, Magnus Bäcklund, Kristina Lång, Ann H. Rosendahl, Mikael Eriksson, Signe Borgquist, Staffan Strömblad, Kamila Czene, Per Hall, Marike Gabrielson

Testo

Distinct mechanisms of resistance to fulvestrant treatment dictate level of ER independence and selective response to CDK inhibitors in metastatic breast cancer di Kamila Kaminska, Nina Akrap, Johan Staaf, Carla L. Alves, Anna Ehinger, Anna Ebbesson, Ingrid Hedenfalk, Lukas Beumers, Srinivas Veerla, Katja Harbst, Sidse Ehmsen, Signe Borgquist, Åke Borg, Alejandro Pérez-Fidalgo, Henrik J. Ditzel, Ana Bosch, Gabriella Honeth

Testo

Dynamic whole-body [18F]FES PET/CT increases lesion visibility in patients with metastatic breast cancer di Mette A. Pedersen, Ole L. Munk, André H. Dias, Johanne H. Steffensen, Anders L. Møller, Anna Lyhne Johnsson, Kim Vang Hansen, Dirk Bender, Steen Jakobsen, Morten Busk, Lars C. Gormsen, Trine Tramm, Signe Borgquist, Mikkel H. Vendelbo

Testo